TY - CHAP AU - Kaori Nomura AU - Brian David Edwards ED - Arli Aditya Y1 - 2018-04-12 PY - 2018 T1 - Frameworks for Evaluating Qualitative and Quantitative Information on Adverse Drug Events throughout Development through to Marketing N2 - The approaches in drug design are mainly comprised of these three multidisciplinary sciences. First, Bioinformatics has successfully gather biological data in form of biomolecular sequences, in order to construct knowledge on drug and vaccine design. It is of considerable importance for drug designers to comprehend the utilization of bioinformatics tools for resolving their research questions. Second, Nanotechnology has made possible the design and delivery of the nano-based drug. Third, Pharmaceutical Chemistry made it possible to investigate the adsorption, distribution, metabolism, and toxicology of the drug candidates in a fine-grained resolution. BT - Molecular Insight of Drug Design SP - Ch. 2 UR - https://doi.org/10.5772/intechopen.76331 DO - 10.5772/intechopen.76331 SN - 978-1-78923-633-0 PB - IntechOpen CY - Rijeka Y2 - 2024-03-28 ER -